{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:33:12Z","timestamp":1790098392712,"version":"4.0.1"},"reference-count":49,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1097\/mop.0b013e32832db986","type":"journal-article","created":{"date-parts":[[2009,7,20]],"date-time":"2009-07-20T03:24:08Z","timestamp":1248060248000},"page":"475-480","source":"Crossref","is-referenced-by-count":31,"title":["An update on alopecia areata"],"prefix":"10.1097","volume":"21","author":[{"given":"Liborka","family":"Kos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Conlon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20210206","first-page":"104","article-title":"Alopecia areata in children","volume":"82","author":"Hawit","year":"2008","journal-title":"Cutis"},{"key":"R2-10-20210206","first-page":"367","article-title":"Alopecia areata: genetic complexity underlies clinical heterogeneity","volume":"17","author":"Dudda-Subramanya","year":"2007","journal-title":"Eur J Dermatol"},{"key":"R3-10-20210206","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1172\/JCI31942","article-title":"Lymphocytes, neuropeptides, and genes involved in alopecia areata","volume":"117","author":"Gilhar","year":"2007","journal-title":"J Clin Invest"},{"key":"R4-10-20210206","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1365-4632.2007.03193.x","article-title":"Alopecia areata","volume":"46","author":"Wasserman","year":"2007","journal-title":"Int J Dermatol"},{"key":"R5-10-20210206","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1038\/sj.jid.5701183","article-title":"Maintenance of hair follicle immune privilege is linked to prevention of NK cell attack","volume":"128","author":"Ito","year":"2008","journal-title":"J Invest Dermatol"},{"key":"R6-10-20210206","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1086\/511442","article-title":"Genomewide scan for linkage reveals evidence of several susceptibility loci for alopecia areata","volume":"80","author":"Martinez-Mir","year":"2007","journal-title":"Am J Hum Genet"},{"key":"R7-10-20210206","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/sj.jid.5700973","article-title":"Human leukocyte antigen class II alleles are associated with risk of alopecia areata","volume":"128","author":"Barahmani","year":"2008","journal-title":"J Invest Dermatol"},{"key":"R8-10-20210206","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/sj.jid.5700009","article-title":"Major histocompatibility complex class I chain-related gene A polymorphisms and extended haplotypes are associated with familial alopecia areata","volume":"126","author":"Barahmani","year":"2006","journal-title":"J Invest Dermatol"},{"key":"R9-10-20210206","first-page":"639","article-title":"Structure and polymorphism of the human gene for the interferon-induced p78 protein (MX1): evidence of association with alopecia areata in the Down syndrome region","volume":"106","author":"Tazi-Ahnini","year":"2000","journal-title":"Hum Genet"},{"key":"R10-10-20210206","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1399-0039.2007.00992.x","article-title":"Genetic analysis of autoimmune regulator haplotypes in alopecia areata","volume":"71","author":"Wengraf","year":"2008","journal-title":"Tissue Antigens"},{"key":"R11-10-20210206","first-page":"389","article-title":"The R620W polymorphism in PTPN22 confers general susceptibility for the development of alopecia areata","volume":"158","author":"Betz","year":"2008","journal-title":"Br J Dermatol"},{"key":"R12-10-20210206","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jaad.2008.09.049","article-title":"Increased history of childhood and lifetime traumatic events among adults with alopecia areata","volume":"60","author":"Willemsen","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"R13-10-20210206","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1468-3083.2008.02748.x","article-title":"Alopecia areata and relationship with stressful events in children","volume":"23","author":"Manolache","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R14-10-20210206","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.2353\/ajpath.2007.061206","article-title":"Probing the effects of stress mediators on the human hair follicle: substance P holds central position","volume":"171","author":"Peters","year":"2007","journal-title":"Am J Pathol"},{"key":"R15-10-20210206","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1038\/jid.2008.371","article-title":"Development of alopecia areata is associated with higher central and peripheral hypothalamic-pituitary-adrenal tone in the skin graft induced C3H\/HeJ mouse model","volume":"129","author":"Zhang","year":"2009","journal-title":"J Invest Dermatol"},{"key":"R16-10-20210206","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1468-3083.2006.01931.x","article-title":"A case series of alopecia areata in children: impact of personal and family history of stress and autoimmunity","volume":"21","author":"Kakourou","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R17-10-20210206","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1038\/sj.jid.5700915","article-title":"Loss-of-function mutations in the filaggrin gene and alopecia areata: strong risk factor for a severe course of disease in patients comorbid for atopic dermatitis","volume":"127","author":"Betz","year":"2007","journal-title":"J Invest Dermatol"},{"key":"R18-10-20210206","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jaad.2006.05.008","article-title":"Alopecia areata: a long term follow-up study of 191 patients","volume":"55","author":"Tosti","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"R19-10-20210206","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/j.1468-3083.2008.02699.x","article-title":"Alopecia areata in Turkey: demographic and clinical features","volume":"22","author":"Kavak","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R20-10-20210206","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1111\/j.1468-3083.2006.01676.x","article-title":"Profile of 513 patients with alopecia areata: associations of disease subtypes with atopy, autoimmune disease and positive family history","volume":"20","author":"Goh","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R22-10-20210206","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1046\/j.1365-4362.2003.01862.x","article-title":"Efficacy of betamethasone valerate foam formulation in comparison with betamethasone dipropionate lotion in the treatment of mild-to-moderate alopecia areata: a multicenter, prospective, randomized, controlled, investigator-blinded trial","volume":"42","author":"Mancuso","year":"2003","journal-title":"Int J Dermatol"},{"issue":"Suppl 2","key":"R23-10-20210206","first-page":"222","article-title":"Efficacy and safety of a new clobetasol propionate 0.05% foam in alopecia areata: a randomized, double-blind placebo controlled trial","volume":"19","author":"Tosti","year":"2005","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"R24-10-20210206","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S0190-9622(87)70095-4","article-title":"Double-blind, placebo-controlled evaluation on topical minoxidil in extensive alopecia areata","volume":"16","author":"Price","year":"1987","journal-title":"J Am Acad Dermatol"},{"key":"R25-10-20210206","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jaad.2004.05.019","article-title":"Topical tacrolimus in alopecia areata","volume":"52","author":"Price","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"R26-10-20210206","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1365-2133.1971.tb07230.x","article-title":"A comparison of intra-lesional triamcinolone hexacetonide and triamcinolone acetonide in alopecia areata","volume":"85","author":"Porter","year":"1971","journal-title":"Br J Dermatol"},{"key":"R27-10-20210206","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jaad.2004.10.873","article-title":"Placebo-controlled oral pulse prednisolone therapy in alopecia areata","volume":"52","author":"Kar","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"R28-10-20210206","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.jaad.2005.07.056","article-title":"Is oral pulsed prednisolone useful in alopecia areata? Critical appraisal of a randomized trial [letter]","volume":"53","author":"Sladden","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"R29-10-20210206","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1159\/000107626","article-title":"Pulse corticosteroid therapy for alopecia areata: study of 139 patients","volume":"125","author":"Nakajima","year":"2007","journal-title":"Dermatol"},{"key":"R30-10-20210206","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1610-0387.2007.06608.x","article-title":"High-dose intravenous corticosteroid pulse therapy in alopecia areata: Own experience compared with the literature [in German]","volume":"6","author":"Luggen","year":"2008","journal-title":"J Dtsch Dermatol Ges"},{"key":"R31-10-20210206","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1111\/j.1365-2133.2008.08458.x","article-title":"Poor long-term outcome of severe alopecia areata in children treated with high dose pulse corticosteroid therapy","volume":"158","author":"Hubiche","year":"2008","journal-title":"Br J Dermatol"},{"issue":"5","key":"R32-10-20210206","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0190-9622(98)70048-9","article-title":"Efficacy of topical sensitizers in the treatment of alopecia areata","volume":"39","author":"Rokhsar","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"R33-10-20210206","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/BF00418577","article-title":"Dichloronitrobenzene: influence on the cytochrome p450 system and mutagenic effects","volume":"266","author":"Kratka","year":"1979","journal-title":"Arch Dermatol Res"},{"key":"R34-10-20210206","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/BF00371623","article-title":"Topical immunotherapy with contact allergens in alopecia areata: evidence for nonspecific systemic suppression of cellular immune reactions","volume":"283","author":"Br\u00f6cker","year":"1991","journal-title":"Arch Dermatol Res"},{"issue":"2","key":"R35-10-20210206","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0190-9622(96)90323-0","article-title":"Long-term results of topical immunotherapy in children with alopecia totalis or alopecia universalis","volume":"35","author":"Tosti","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"R36-10-20210206","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1001\/archderm.1992.01680140098011","article-title":"Dyschromia in confetti as a side effect of topical immunotherapy with diphenylcyclopropenone","volume":"128","author":"Van der Steen","year":"1992","journal-title":"Arch Dermatol"},{"key":"R37-10-20210206","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.jaad.2004.05.026","article-title":"308-nm excimer laser therapy in alopecia areata","volume":"51","author":"Zakaria","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"R38-10-20210206","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1097\/00042728-200712000-00011","article-title":"308-nm excimer laser for the treatment of alopecia areata","volume":"33","author":"Al-Mutairi","year":"2007","journal-title":"Dermatol Surg"},{"key":"R39-10-20210206","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1111\/j.1365-4632.2005.02542.x","article-title":"Infant alopecia universalis: role of topical PUVA (psoralen ultraviolet A) radiation","volume":"44","author":"Yoon","year":"2005","journal-title":"Int J Dermatol"},{"key":"R40-10-20210206","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1365-2230.2008.02712.x","article-title":"Failure to treat alopecia areata with photodynamic therapy","volume":"33","author":"Fern\u00e1ndez-Guarino","year":"2008","journal-title":"Clin Exp Dermatol"},{"key":"R41-10-20210206","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1111\/j.1468-3083.2008.02665.x","article-title":"Successful treatment of alopecia areata with efalizumab [letter]","volume":"22","author":"Kolde","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R42-10-20210206","first-page":"431","article-title":"Successful treatment of alopecia universalis with alefacept: a case report and review of literature","volume":"81","author":"Bui","year":"2008","journal-title":"Cutis"},{"key":"R43-10-20210206","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.jaad.2005.03.039","article-title":"Etanercept does not effectively treat moderate to severe alopecia areata: an open-label study","volume":"52","author":"Strober","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"R44-10-20210206","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jaad.2007.10.645","article-title":"Subcutaneous efalizumab is not effective in the treatment of alopecia areata","volume":"58","author":"Price","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"R45-10-20210206","first-page":"759","article-title":"Recurrence of alopecia areata in a patient receiving etanercept injections","volume":"141","author":"Posten","year":"2004","journal-title":"Arch Dermatol"},{"key":"R46-10-20210206","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1001\/archderm.140.8.1012-a","article-title":"Alopecia areata in a patient using infliximab: new insights into the role of tumor necrosis factor on human hair follicles","volume":"140","author":"Ettefagh","year":"2004","journal-title":"Arch Dermatol"},{"key":"R47-10-20210206","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1159\/000113945","article-title":"Alopecia areata universalis elicited during treatment with adalimumab","volume":"216","author":"Pelivani","year":"2008","journal-title":"Dermatol"},{"key":"R48-10-20210206","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1159\/000162180","article-title":"Alopecia areata universalis during treatment of rheumatoid arthritis with anti-TNF-\u03b1 antibody (adalimumab)","volume":"217","author":"Chaves","year":"2008","journal-title":"Dermatol"},{"issue":"5","key":"R49-10-20210206","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.jaad.2005.06.031","article-title":"Lack of efficacy of topical latanoprost in the treatment of eyebrow alopecia areata","volume":"53","author":"Ross","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"R50-10-20210206","doi-asserted-by":"crossref","first-page":"650","DOI":"10.2353\/ajpath.2008.061249","article-title":"Controlled delivery of T-box21 small interfering RNA ameliorates autoimmune alopecia (alopecia areata) in C3H\/HeJ mouse model","volume":"172","author":"Nakamura","year":"2008","journal-title":"Am J Pathol"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MOP.0b013e32832db986","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:55:43Z","timestamp":1786038943000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00008480-200908000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0b013e32832db986","relation":{},"ISSN":["1040-8703"],"issn-type":[{"value":"1040-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8]]}}}